These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21993428)

  • 1. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
    Coons SJ; Kothari S; Monz BU; Burke LB
    Clin Pharmacol Ther; 2011 Nov; 90(5):743-8. PubMed ID: 21993428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010.
    DeMuro C; Clark M; Mordin M; Fehnel S; Copley-Merriman C; Gnanasakthy A
    Value Health; 2012 May; 15(3):443-8. PubMed ID: 22583454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
    Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
    Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of patient-reported outcome labels in the United States: 2006 to 2010.
    Gnanasakthy A; Mordin M; Clark M; DeMuro C; Fehnel S; Copley-Merriman C
    Value Health; 2012 May; 15(3):437-42. PubMed ID: 22583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: report of the ISPOR ePRO systems validation good research practices task force.
    Zbrozek A; Hebert J; Gogates G; Thorell R; Dell C; Molsen E; Craig G; Grice K; Kern S; Hines S
    Value Health; 2013 Jun; 16(4):480-9. PubMed ID: 23796281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes to support medical product labeling claims: FDA perspective.
    Patrick DL; Burke LB; Powers JH; Scott JA; Rock EP; Dawisha S; O'Neill R; Kennedy DL
    Value Health; 2007; 10 Suppl 2():S125-37. PubMed ID: 17995471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels.
    Basch E
    Value Health; 2012 May; 15(3):401-3. PubMed ID: 22583448
    [No Abstract]   [Full Text] [Related]  

  • 10. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
    Acquadro C; Berzon R; Dubois D; Leidy NK; Marquis P; Revicki D; Rothman M;
    Value Health; 2003; 6(5):522-31. PubMed ID: 14627058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force.
    Eremenco S; Coons SJ; Paty J; Coyne K; Bennett AV; McEntegart D;
    Value Health; 2014 Jul; 17(5):501-16. PubMed ID: 25128043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes (PROs) in dental clinical trials and product development: introduction to scientific and regulatory considerations.
    Gwaltney CJ
    J Evid Based Dent Pract; 2010 Jun; 10(2):86-90. PubMed ID: 20466315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.
    Hao Y
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):407-20. PubMed ID: 20715918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper.
    Baiardini I; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; van Wijk RG; La Grutta S; Lombardi C; Maurer M; Pinto AM; Ridolo E; Senna GE; Terreehorst I; Bom AT; Bousquet J; Zuberbier T; Braido F;
    Allergy; 2010 Mar; 65(3):290-5. PubMed ID: 19930232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.
    Brozek JL; Guyatt GH; Schünemann HJ
    Health Qual Life Outcomes; 2006 Sep; 4():69. PubMed ID: 17005037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing patients' perspectives of treatment in clinical trials/drug development.
    Hareendran A; Gnanasakthy A; Winnette R; Revicki D
    Contemp Clin Trials; 2012 Jan; 33(1):23-8. PubMed ID: 22001362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model.
    Bruner DW
    J Natl Cancer Inst Monogr; 2007; (37):12-5. PubMed ID: 17951225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating the science of patient-reported outcomes assessment into clinical practice.
    Osoba D
    J Natl Cancer Inst Monogr; 2007; (37):5-11. PubMed ID: 17951224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
    Cleeland CS; Sloan JA;
    J Pain Symptom Manage; 2010 Jun; 39(6):1077-85. PubMed ID: 20538189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research.
    Kerr C; Nixon A; Wild D
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):269-81. PubMed ID: 20545592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.